(4-Methoxy-2,6-dimethylphenyl)oxo-acetic acid ethyl ester, 97.0%, 1g

tert-Butyl-3-hydroxypropionate, 95.0%, 5g

2-((2-Chlorobenzyl)amino)butan-1-ol, 95%, 100mg

ISPINESIB, 98%, 50mg

methyl 1-(cyanomethyl)-1H-1,2,4-triazole-3-carboxylate, 95.0%, 500mg

Plan PLPH S40x/0.65 phase contrast objective

4-Methylsulfonylphenylisothiocyanate, 98.0%, 5g

tert-Butyl 4-(2-bromophenylsulfonamido)piperidine-1-carboxylate, 95.0%, 1g

4-((2,4-Difluorophenoxy)methyl)piperidine hydrochloride, 95%, 500mg

1-(Cyclopentylmethyl)piperazine dihydrochloride, 95.0%, 2.5g

Fmoc-Glu(OMe)-OH, 98%, 10g

LEVOSULPIRIDE, 96%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(((tert-butoxycarbonyl)amino)methyl)phenyl)propanoic acid, 97%, 250mg